B CELL ALL
Clinical trials for B CELL ALL explained in plain language.
Never miss a new study
Get alerted when new B CELL ALL trials appear
Sign up with your email to follow new studies for B CELL ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple drug tame CAR-T's dangerous side effects?
Disease control OngoingThis study tests whether the drug anakinra can prevent or reverse severe side effects from CAR-T cell therapy, a powerful cancer treatment. About 62 adults with certain B-cell cancers (like leukemia or lymphoma) will receive anakinra alongside their CAR-T cells. The goal is to re…
Matched conditions: B CELL ALL
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Engineered donor cells take aim at returning blood cancers after transplant
Disease control OngoingThis early-phase study tests a new approach for people whose lymphoma or leukemia has returned after a donor stem cell transplant. Researchers take T cells from the original stem cell donor, add a special receptor (anti-CD19) to help them recognize and attack cancer cells, and in…
Matched conditions: B CELL ALL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC